Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wiegmann

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Pediatric Nephrology (Berlin, Germany)|November 5, 1997
Renal structural-functional relationships in early diabetes mellitusE N Ellis, B A Warady, E G Wood, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2007
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuriaHiddo Lambers Heerspink, Tom Greene, Julia B Lewis, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2011
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathyDavid K Packham, Rory Wolfe, Anne T Reutens, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy TrialTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 5, 2013
Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Pediatric Nephrology (Berlin, Germany)|November 5, 1997
Renal structural-functional relationships in early diabetes mellitusE N Ellis, B A Warady, E G Wood, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2007
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuriaHiddo Lambers Heerspink, Tom Greene, Julia B Lewis, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2011
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathyDavid K Packham, Rory Wolfe, Anne T Reutens, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy TrialTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 5, 2013
Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Pageof 7